RxDoctor Payments DataLook up a doctor →

Joseph Laukaitis, MD

Rheumatology · Washington, DCNPI 1083726210

Payments from drug & device makers

$9,571in general payments, 2019–2025

Across 481 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Lilly USA, LLC$1K
  • Johnson & Johnson$1K
  • Novartis$1K
  • AbbVie$567
  • AstraZeneca$537
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$9,569100%
  • Education$20%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,571 in reported general payments places this provider in the 60th percentile of 41 rheumatology providers in District of Columbia.

See all rheumatology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$27,575
Medicare patients
136
Services billed
430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab16$272,340
Enbrel SureclickEtanercept16$172,522
Cevimeline Hcl19$3,995
MethotrexateMethotrexate Sodium50$2,720
Hydroxychloroquine Sulfate24$1,339
Alendronate Sodium45$818
Allopurinol42$585
Pregabalin12$575
Meloxicam37$421
Duloxetine Hcl20$312
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen15$271
Prednisone19$227
Diclofenac Sodium18$180
Folic Acid14$153

Paid to pharmacies, not to this prescriber.

Other rheumatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →